United Therapeutics received a decision from the U.S. Court of Appeals regarding the cancellation of their patent, which could potentially allow Liquidia to launch a competing product.
AI Assistant
UNITED THERAPEUTICS CORP
2023
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.